EAGLE PHARMACEUTICALS, INC. (EGRX)

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

Address

50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE, NJ 07677

Founded

2007

Number of Employees

-

Website

http://www.eagleus.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 - - $37,183 $43,541 $73,107 $17,960 $32,035 $21,220 $18,017 - - $34,723
Average Price - - $65.60 $64.52 $54.21 $56.58 $41.15 $49.41 $40.85 - - $53.34
# Shares Purchased - - 566,838 674,857 1,348,563 317,429 778,465 429,446 441,108 - - 650,958
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - -93.9% -93.8% -92.6% -92.9% -90.3% -91.9% -90.2% - - -92.5%
S&P 500 Return to Date - - 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% - - 91.4%
Excess Total Return - - -262.5% -223.5% -197.5% -186.0% -165.1% -123.6% -127.5% - - -183.9%
Quartile Rank
Percentile Rank - - 1% 1% 1% 1% 2% 2% 1% - - 2%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
SUPERNUS PHARMACEUTICALS, INC.
TARRIFF SCOTT

EAGLE PHARMACEUTICALS, INC.
EDLIN RICHARD A.

EAGLE PHARMACEUTICALS, INC.
XENCOR INC

Inmune Bio, Inc.